Denali Therapeutics Inc.
ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF

Last updated:

Abstract:

In one aspect, antibodies that specifically bind to a human triggering receptor expressed on myeloid cells 2 (TREM2) protein are provided. In some embodiments, the antibody decreases levels of soluble TREM2 (sTREM2). In some embodiments, the antibody enhances TREM2 activity.

Status:
Application
Type:

Utility

Filling date:

16 Aug 2021

Issue date:

10 Mar 2022